25 May 2013
Keywords: merck, kgaa, file, erbitux, eu, following, release
Article | 09 June 2003
Bernhard Scheuble, chief executive of Germany's Merck KGaA, has said that promising new data on the cancer drug Erbitux (cetuximab), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2003
16 June 2003
24 May 2013
© 2013 thepharmaletter.com